Guidelines for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
The DOI matches its Crossref record; 1,088 of the 1,095 references it cites were found in a registry or an index.
Abstract
The aim of this updated guideline is to provide comprehensive and timely evidence-based recommendations on the prevention of future stroke among survivors of ischemic stroke or transient ischemic attack. The guideline is addressed to all clinicians who manage secondary prevention for these patients. Evidence-based recommendations are provided for control of risk factors, intervention for vascular obstruction, antithrombotic therapy for cardioembolism, and antiplatelet therapy for noncardioembolic stroke. Recommendations are also provided for the prevention of recurrent stroke in a variety of specific circumstances, including aortic arch atherosclerosis, arterial dissection, patent foramen ovale, hyperhomocysteinemia, hypercoagulable states, antiphospholipid antibody syndrome, sickle cell disease, cerebral venous sinus thrombosis, and pregnancy. Special sections address use of antithrombotic and anticoagulation therapy after an intracranial hemorrhage and implementation of guidelines.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Treatment of insulin resistance represents a potential new preventive strategy that could be added to standard care after ischemic stroke or TIA.5”
From Pioglitazone after Ischemic Stroke or Transient Ischemic Attack (2016) · cites this paper as [5]
In the citing paper
“Affected trial reports were cited in nine effectiveness reviews and clinical guidelines (one published in Scotland, the others in the USA), for stroke,49 fracture prevention50–55 and fall and injury prevention.56”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [49]
In the citing paper
“American stroke guidelines49 (1230 citations, November 2018) used evidence from one report14 of vitamin B12 and folate supplementation as the only evidence when discussing fracture prevention among patients with a recent ischaemic stroke.”
From An investigation into the impact and implications of published papers from retracted research: systematic search of affected literature (2019) · cites this paper as [49]
In the citing paper
“It is important to evaluate patients with stroke or transient ischemic attack (TIA) for atrial fibrillation (AF), because the detection of AF changes the recommended anti-thrombotic regimen from treatment with an antiplatelet agent to treatment with oral anticoagulation (1).”
From Diagnostic Yield of Extended Cardiac Patch Monitoring in Patients with Stroke or TIA (2015) · cites this paper as [1]
Citations
Cites
2 retracted
Items 201–400 of 1,088
The way I see it: House officers need formal career development
Connor, A. (2002) · BMJ · doi:10.1136/bmj.324.7336.s71 · Cited by 1,143
ACC/AHA guidelines for the management of patients with valvular heart disease
Bonow, R., Carabello, B., de Leon, A., Edmunds, L. H., Fedderly, B., Freed, M., Gaasch, W., McKay, C., Nishimura, R., O’Gara, P., et al. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00454-9 · Cited by 1,134
Iso, H., Jacobs, D. R., Wentworth, D., Neaton, J. D., Cohen, J. D., & for the MRFIT Research Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198904063201405 · Cited by 1,133
Fruit and vegetable consumption and stroke: meta-analysis of cohort studies
He, F. J., Nowson, C. A., & MacGregor, G. A. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68069-0 · Cited by 1,108
Resistance to Activated Protein C as a Basis for Venous Thrombosis
Svensson, P. J., & Dahlback, B. (1994) · New England Journal of Medicine · doi:10.1056/nejm199402243300801 · Cited by 1,102
Howard, B. V., Van Horn, L., Hsia, J., Manson, J. E., Stefanick, M. L., Wassertheil-Smoller, S., Kuller, L. H., LaCroix, A. Z., Langer, R. D., Lasser, N. L., et al. (2006) · JAMA · doi:10.1001/jama.295.6.655 · Cited by 1,091
Self-citation2012 Writing Committee Members, Jneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., et al. (2012) · Circulation · doi:10.1161/cir.0b013e318256f1e0 · Cited by 1,090
Mortality among Patients Admitted to Hospitals on Weekends as Compared with Weekdays
Bell, C. M., & Redelmeier, D. A. (2001) · New England Journal of Medicine · doi:10.1056/nejmsa003376 · Cited by 1,070
Thromboembolic and bleeding complications in patients with mechanical heart valve prostheses.
Cannegieter, S. C., Rosendaal, F. R., & Briët, E. (1994) · Circulation · doi:10.1161/01.cir.89.2.635 · Cited by 1,068
Hylek, E. M., Evans-Molina, C., Shea, C., Henault, L. E., & Regan, S. (2007) · Circulation · doi:10.1161/circulationaha.106.653048 · Cited by 1,061
Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale
Furlan, A. J., Reisman, M., Massaro, J., Mauri, L., Adams, H., Albers, G. W., Felberg, R., Herrmann, H., Kar, S., Landzberg, M., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1009639 · Cited by 1,060
Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus
Buse, J. B., Ginsberg, H. N., Bakris, G. L., Clark, N. G., Costa, F., Eckel, R., Fonseca, V., Gerstein, H. C., Grundy, S., Nesto, R. W., et al. (2007) · Diabetes Care · doi:10.2337/dc07-9917 · Cited by 1,055
Meta-analysis of relation between cigarette smoking and stroke.
Shinton, R., & Beevers, G. (1989) · BMJ · doi:10.1136/bmj.298.6676.789 · Cited by 1,039
Ridker, P. M., Hennekens, C. H., Lindpaintner, K., Stampfer, M. J., Eisenberg, P. R., & Miletich, J. P. (1995) · New England Journal of Medicine · doi:10.1056/nejm199504063321403 · Cited by 1,035
Gaziano, J. M., Buring, J. E., Breslow, J. L., Goldhaber, S. Z., Rosner, B., VanDenburgh, M., Willett, W., & Hennekens, C. H. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292501 · Cited by 1,024
Antiplatelet agents for preventing pre-eclampsia and its complications
Duley, L., Henderson-Smart, D. J., Meher, S., & King, J. F. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004659.pub2 · Cited by 1,016
Pearson, T. A., Laurora, I., Chu, H., & Kafonek, S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.4.459 · Cited by 1,012
Continuous positive airways pressure for obstructive sleep apnoea in adults
Giles, T., Lasserson, T., Smith, B., White, J., Wright, J., & Cates, C. (2006) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001106.pub2 · Cited by 1,001
Heparin treatment in sinus venous thrombosis
Einhäupl, K. M., Villringer, A., Mehraein, S., Garner, C., Pellkofer, M., Haberl, R. L., Pfister, H.-W., Schmiedek, P., & Meister, W. (1991) · The Lancet · doi:10.1016/0140-6736(91)90607-q · Cited by 992
Fibrinogen as a Cardiovascular Risk Factor: A Meta-Analysis and Review of the Literature
Ernst, E., & Resch, K. L. (1993) · Annals of Internal Medicine · doi:10.7326/0003-4819-118-12-199306150-00008 · Cited by 990
Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke
Carroll, J. D., Saver, J. L., Thaler, D. E., Smalling, R. W., Berry, S., MacDonald, L. A., Marks, D. S., & Tirschwell, D. L. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1301440 · Cited by 983
Carotid Endarterectomy and Prevention of Cerebral Ischemia in Symptomatic Carotid Stenosis
Mayberg, M. R. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470230047029 · Cited by 964
Roach, E. S., Golomb, M. R., Adams, R., Biller, J., Daniels, S., deVeber, G., Ferriero, D., Jones, B. V., Kirkham, F. J., Scott, R. M., et al. (2008) · Stroke · doi:10.1161/strokeaha.108.189696 · Cited by 963
Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke
Sacco, R. L., Diener, H.-C., Yusuf, S., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0805002 · Cited by 961
A Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
The Canadian Cooperative Study Group (1978) · New England Journal of Medicine · doi:10.1056/nejm197807132990201 · Cited by 957
Association of Sleep-disordered Breathing and the Occurrence of Stroke
Arzt, M., Young, T., Finn, L., Skatrud, J. B., & Bradley, T. D. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200505-702oc · Cited by 951
Homma, S., Sacco, R. L., Di Tullio, M. R., Sciacca, R. R., & Mohr, J. P. (2002) · Circulation · doi:10.1161/01.cir.0000017498.88393.44 · Cited by 949
Effect of Sibutramine on Cardiovascular Outcomes in Overweight and Obese Subjects
James, W. P. T., Caterson, I. D., Coutinho, W., Finer, N., Van Gaal, L. F., Maggioni, A. P., Torp-Pedersen, C., Sharma, A. M., Shepherd, G. M., Rode, R. A., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1003114 · Cited by 943
Aburto, N. J., Hanson, S., Gutierrez, H., Hooper, L., Elliott, P., & Cappuccio, F. P. (2013) · BMJ · doi:10.1136/bmj.f1378 · Cited by 938
Interatrial septal abnormalities and stroke: A meta-analysis of case-control studies
Overell, J. R., Bone, I., & Lees, K. R. (2000) · Neurology · doi:10.1212/wnl.55.8.1172 · Cited by 936
Effects of fibrates on cardiovascular outcomes: a systematic review and meta-analysis
Jun, M., Foote, C., Lv, J., Neal, B., Patel, A., Nicholls, S. J., Grobbee, D. E., Cass, A., Chalmers, J., & Perkovic, V. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60656-3 · Cited by 927
Type 2 diabetes across generations: from pathophysiology to prevention and management
Nolan, C. J., Damm, P., & Prentki, M. (2011) · The Lancet · doi:10.1016/s0140-6736(11)60614-4 · Cited by 923 · cited 1×
“ily by excess calorie intake in people who are susceptible by virtue of inherited traits, age, and acquired behaviors.(54,112) In”
BackgroundA Clinical Trial of Estrogen-Replacement Therapy after Ischemic Stroke
Viscoli, C. M., Brass, L. M., Kernan, W. N., Sarrel, P. M., Suissa, S., & Horwitz, R. I. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa010534 · Cited by 921
Self-citationPercutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
Meier, B., Kalesan, B., Mattle, H. P., Khattab, A. A., Hildick-Smith, D., Dudek, D., Andersen, G., Ibrahim, R., Schuler, G., Walton, A. S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211716 · Cited by 920
Crowther, M. A., Ginsberg, J. S., Julian, J., Denburg, J., Hirsh, J., Douketis, J., Laskin, C., Fortin, P., Anderson, D., Kearon, C., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035241 · Cited by 919
Antithrombotic Therapy for Atrial Fibrillation
You, J. J., Singer, D. E., Howard, P. A., Lane, D. A., Eckman, M. H., Fang, M. C., Hylek, E. M., Schulman, S., Go, A. S., Hughes, M., et al. (2012) · Chest · doi:10.1378/chest.11-2304 · Cited by 918
Self-citationTHE CANADIAN AMERICAN TICLOPIDINE STUDY (CATS) IN THROMBOEMBOLIC STROKE
Gent, M., Donald Easton, J., Hachinski, V., Panak, E., Sicurella, J., Blakely, J., Ellis, D., Harbison, J., Roberts, R., & Turpie, A. G. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92327-1 · Cited by 910
Optimal Oral Anticoagulant Therapy in Patients with Mechanical Heart Valves
Cannegieter, S. C., Rosendaal, F. R., Wintzen, A. R., van der Meer, F. J. M., Vandenbroucke, J. P., & Briet, E. (1995) · New England Journal of Medicine · doi:10.1056/nejm199507063330103 · Cited by 908
Stampfer, M. J., Colditz, G. A., Willett, W. C., Speizer, F. E., & Hennekens, C. H. (1988) · New England Journal of Medicine · doi:10.1056/nejm198808043190503 · Cited by 903
Bedside monitoring to adjust antiplatelet therapy for coronary stenting
Collet, J.-P., Cuisset, T., Rangé, G., Cayla, G., Elhadad, S., Pouillot, C., Henry, P., Motreff, P., Carrié, D., Boueri, Z., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1209979 · Cited by 887
Perry, I. J., Morris, R. W., Ebrahim, S. B., Shaper, A. G., Refsum, H., & Ueland, P. M. (1995) · The Lancet · doi:10.1016/s0140-6736(95)92407-8 · Cited by 883
Derdeyn, C. P., Chimowitz, M. I., Lynn, M. J., Fiorella, D., Turan, T. N., Janis, L. S., Montgomery, J., Nizam, A., Lane, B. F., Lutsep, H. L., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62038-3 · Cited by 881
Self-citationGlotzer, T. V., Daoud, E. G., Wyse, D. G., Singer, D. E., Ezekowitz, M. D., Hilker, C., Miller, C., Qi, D., & Ziegler, P. D. (2009) · Circulation: Arrhythmia and Electrophysiology · doi:10.1161/circep.109.849638 · Cited by 879 · cited 1×
“A similar rate of occult AF has been reported among high-risk nonstroke patients with implantable cardiac rhythm devices.(412,413) Occult AF detected during pacemaker interrogation in stroke-free patients or mixed populations is associated with increased risk for stroke.”
BackgroundSelf-citationHansen, M. L., Sørensen, R., Clausen, M. T., Fog-Petersen, M. L., Raunsø, J., Gadsbøll, N., Gislason, G. H., Folke, F., Andersen, S. S., Schramm, T. K., et al. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.271 · Cited by 855 · cited 6×
“therapy is at least as effective as antiplatelet therapy for prevention of MI.(438,559) Therefore, in most patients with AF with”
BackgroundInfluentialBolland, M. J., Grey, A., Avenell, A., Gamble, G. D., & Reid, I. R. (2011) · BMJ · doi:10.1136/bmj.d2040 · Cited by 851
Enriquez-Sarano, M., Akins, C. W., & Vahanian, A. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60692-9 · Cited by 850
Warfarin, Aspirin, or Both after Myocardial Infarction
Hurlen, M., Abdelnoor, M., Smith, P., Erikssen, J., & Arnesen, H. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa020496 · Cited by 846
MORTALITY AMONG PATIENTS ADMITTED TO HOSPITALS ON WEEKENDS AS COMPARED WITH WEEKDAYS
Ell, C., & Edelmeier, A. R. (2001) · Cited by 844
Ruiz-Irastorza, G., Crowther, M., Branch, W., & Khamashta, M. A. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60709-x · Cited by 831
Broderick, J. P., Adams, H. P., Barsan, W., Feinberg, W., Feldmann, E., Grotta, J., Kase, C., Krieger, D., Mayberg, M., Tilley, B., et al. (1999) · Stroke · doi:10.1161/01.str.30.4.905 · Cited by 830
The Perioperative Management of Antithrombotic Therapy
Douketis, J. D., Berger, P. B., Dunn, A. S., Jaffer, A. K., Spyropoulos, A. C., Becker, R. C., & Ansell, J. (2008) · Chest · doi:10.1378/chest.08-0675 · Cited by 830
Combined pharmacotherapy and behavioural interventions for smoking cessation
Stead, L. F., Koilpillai, P., Fanshawe, T. R., & Lancaster, T. (2016) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008286.pub3 · Cited by 829
Physical Activity and Stroke Risk: A Meta-Analysis
Lee, C. D., Folsom, A. R., & Blair, S. N. (2003) · Stroke · doi:10.1161/01.str.0000091843.02517.9d · Cited by 829
Eckstein, H.-H., Ringleb, P., Allenberg, J.-R., Berger, J., Fraedrich, G., Hacke, W., Hennerici, M., Stingele, R., Fiehler, J., Zeumer, H., et al. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70196-0 · Cited by 826
de Bruijn, S. F. T. M., & Stam, J. (1999) · Stroke · doi:10.1161/01.str.30.3.484 · Cited by 817
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
Warkentin, T. E., & Greinacher, A. (2004) · Chest · doi:10.1378/chest.126.3_suppl.311s · Cited by 809
Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous Thromboembolism
Ridker, P. M., Goldhaber, S. Z., Danielson, E., Rosenberg, Y., Eby, C. S., Deitcher, S. R., Cushman, M., Moll, S., Kessler, C. M., Elliott, C. G., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa035029 · Cited by 808
Importance of Hemodynamic Factors in the Prognosis of Symptomatic Carotid Occlusion
Grubb, Jr. (1998) · JAMA · doi:10.1001/jama.280.12.1055 · Cited by 807
Powers, W. J., Clarke, W. R., Grubb, R. L., Videen, T. O., Adams, H. P., Derdeyn, C. P., & COSS Investigators, F. T. (2011) · JAMA · doi:10.1001/jama.2011.1610 · Cited by 803
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Diseases of the Heart and Circulation
(1957) · Postgraduate Medical Journal · doi:10.1136/pgmj.33.377.147 · Cited by 799
Venous Thromboembolism, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Pabinger, I., Sofaer, S., & Hirsh, J. (2008) · Chest · doi:10.1378/chest.08-0761 · Cited by 793
Brien, S. E., Ronksley, P. E., Turner, B. J., Mukamal, K. J., & Ghali, W. A. (2011) · BMJ · doi:10.1136/bmj.d636 · Cited by 791
Hylek, E. M., Skates, S. J., Sheehan, M. A., & Singer, D. E. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608223350802 · Cited by 789
Telmisartan to Prevent Recurrent Stroke and Cardiovascular Events
Yusuf, S., Diener, H.-C., Sacco, R. L., Cotton, D., Ôunpuu, S., Lawton, W. A., Palesch, Y., Martin, R. H., Albers, G. W., Bath, P., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804593 · Cited by 785
Fiorelli, M., Bastianello, S., von Kummer, R., del Zoppo, G. J., Larrue, V., Lesaffre, E., Ringleb, A. P., Lorenzano, S., Manelfe, C., & Bozzao, L. (1999) · Stroke · doi:10.1161/01.str.30.11.2280 · Cited by 777 · cited 1×
“or cause minimal symptoms, rarely progress in size or extent, and are relatively common occurrences.(777,778) Some case series”
BackgroundHasdai, D. (2002) · European Heart Journal · doi:10.1053/euhj.2002.3193 · Cited by 773
Pioglitazone for Diabetes Prevention in Impaired Glucose Tolerance
DeFronzo, R. A., Tripathy, D., Schwenke, D. C., Banerji, M., Bray, G. A., Buchanan, T. A., Clement, S. C., Henry, R. R., Hodis, H. N., Kitabchi, A. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1010949 · Cited by 766
Schrader, J., Lüders, S., Kulschewski, A., Hammersen, F., Plate, K., Berger, J., Zidek, W., Dominiak, P., Diener, H. C., & the MOSES Study Group (2005) · Stroke · doi:10.1161/01.str.0000166048.35740.a9 · Cited by 766
Wood, D. A. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04235-5 · Cited by 761
Predictors of Ischemic Stroke in the Territory of a Symptomatic Intracranial Arterial Stenosis
Kasner, S. E., Chimowitz, M. I., Lynn, M. J., Howlett-Smith, H., Stern, B. J., Hertzberg, V. S., Frankel, M. R., Levine, S. R., Chaturvedi, S., Benesch, C. G., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.578229 · Cited by 759
Self-citation(1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251801 · Cited by 759
Antithrombotic Therapy in Atrial Fibrillation
Singer, D. E., Albers, G. W., Dalen, J. E., Fang, M. C., Go, A. S., Halperin, J. L., Lip, G. Y. H., & Manning, W. J. (2008) · Chest · doi:10.1378/chest.08-0678 · Cited by 751
Self-citationInterventions for smoking cessation in hospitalised patients
Rigotti, N. A., Clair, C., Munafò, M. R., & Stead, L. F. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001837.pub3 · Cited by 751
Glotzer, T. V., Hellkamp, A. S., Zimmerman, J., Sweeney, M. O., Yee, R., Marinchak, R., Cook, J., Paraschos, A., Love, J., Radoslovich, G., et al. (2003) · Circulation · doi:10.1161/01.cir.0000057981.70380.45 · Cited by 750 · cited 1×
“3% in patients given warfarin compared with 1% for patients given placebo or aspirin.(414,416,417) The optimal intensity of oral anticoagulation for stroke prevention in patients with AF is an INR of 2.”
BackgroundAmarenco, P., Labreuche, J., Lavallée, P., & Touboul, P.-J. (2004) · Stroke · doi:10.1161/01.str.0000147965.52712.fa · Cited by 746
Early risk of recurrence by subtype of ischemic stroke in population-based incidence studies
Lovett, J. K., Coull, A. J., & Rothwell, P. M. (2004) · Neurology · doi:10.1212/01.wnl.0000110311.09970.83 · Cited by 741
Sleep disorders and sleep deprivation: an unmet public health problem
(2007) · Choice Reviews Online · doi:10.5860/choice.44-5682 · Cited by 723
Elective Stenting of the Extracranial Carotid Arteries
Yadav, J. S., Roubin, G. S., Iyer, S., Vitek, J., King, P., Jordan, W. D., & Fisher, W. S. (1997) · Circulation · doi:10.1161/01.cir.95.2.376 · Cited by 715
Blood Pressure and Stroke: An Overview of Published Reviews
Lawes, C. M. M., Bennett, D. A., Feigin, V. L., & Rodgers, A. (2004) · Stroke · doi:10.1161/01.str.0000116869.64771.5a · Cited by 705
Alcohol as a Risk Factor for Type 2 Diabetes
Baliunas, D. O., Taylor, B. J., Irving, H., Roerecke, M., Patra, J., Mohapatra, S., & Rehm, J. (2009) · Diabetes Care · doi:10.2337/dc09-0227 · Cited by 703
Newly identified events in the RE-LY trial
Connolly, S. J., Ezekowitz, M. D., Yusuf, S., Reilly, P. A., & Wallentin, L. (2010) · New England Journal of Medicine · doi:10.1056/nejmc1007378 · Cited by 688 · cited 1×
“associated with less stroke or systemic embolism.(425,426) The”
BackgroundSelf-citationEffects of clopidogrel added to aspirin in patients with recent lacunar stroke
The SPS3 Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1204133 · Cited by 679
Metabolic Syndrome: Connecting and Reconciling Cardiovascular and Diabetes Worlds
Grundy, S. M. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.11.046 · Cited by 679
Manson, J. E. (1991) · Archives of Internal Medicine · doi:10.1001/archinte.151.6.1141 · Cited by 675
Physical activity and risk of cardiovascular disease—a meta-analysis of prospective cohort studies
Li, J., & Siegrist, J. (2012) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph9020391 · Cited by 674
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Morris, R. W. (2005) · Archives of Internal Medicine · doi:10.1001/archinte.165.22.2644 · Cited by 672
Pregnancy and the Risk of Stroke
Kittner, S. J., Stern, B. J., Feeser, B. R., Hebel, J. R., Nagey, D. A., Buchholz, D. W., Earley, C. J., Johnson, C. J., Macko, R. F., Sloan, M. A., et al. (1996) · New England Journal of Medicine · doi:10.1056/nejm199609123351102 · Cited by 665
Self-citationSingh, R. B., Dubnov, G., Niaz, M. A., Ghosh, S., Singh, R., Rastogi, S. S., Manor, O., Pella, D., & Berry, E. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11472-3 · Cited by 663 · cited 1×
“Trials of the Mediterranean diet among patients with CAD, although not definitive, provide strong evidence for protection against recurrent vascular events.(251,252) The only definitive trial of the Mediterranean diet among patients without CVD enrolled patients at high risk and demonstrated a significant effect on th…”
BackgroundGorelick, P. B., Wong, K. S., Bae, H.-J., & Pandey, D. K. (2008) · Stroke · doi:10.1161/strokeaha.107.505776 · Cited by 661
Tonstad, S. (2006) · JAMA · doi:10.1001/jama.296.1.64 · Cited by 660
Amarenco, P., & Labreuche, J. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70058-4 · Cited by 660 · cited 7×
“reduce LDL-C levels, have proved efficacious in reducing primary stroke risk without any significant risk of ICH.(60) In the only trial to date dedicated to the evaluation of secondary”
BackgroundInfluentialRogers, W. J., Canto, J. G., Lambrew, C. T., Tiefenbrunn, A. J., Kinkaid, B., Shoultz, D. A., Frederick, P. D., & Every, N. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00996-7 · Cited by 657
Cooper-DeHoff, R. M., Gong, Y., Handberg, E. M., Bavry, A. A., Denardo, S. J., Bakris, G. L., & Pepine, C. J. (2010) · JAMA · doi:10.1001/jama.2010.884 · Cited by 651
Almdal, T., Scharling, H., Jensen, J. S., & Vestergaard, H. (2004) · Archives of Internal Medicine · doi:10.1001/archinte.164.13.1422 · Cited by 650
Thrombotic Thrombocytopenic Purpura Associated with Clopidogrel
Bennett, C. L., Connors, J. M., Carwile, J. M., Moake, J. L., Bell, W. R., Tarantolo, S. R., McCarthy, L. J., Sarode, R., Hatfield, A. J., Feldman, M. D., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200006153422402 · Cited by 643
Warfarin, hematoma expansion, and outcome of intracerebral hemorrhage
Flibotte, J. J., Hagan, N., O’Donnell, J., Greenberg, S. M., & Rosand, J. (2004) · Neurology · doi:10.1212/01.wnl.0000138428.40673.83 · Cited by 632
Antithrombotic and Thrombolytic Therapy for Valvular Disease
Whitlock, R. P., Sun, J. C., Fremes, S. E., Rubens, F. D., & Teoh, K. H. (2012) · Chest · doi:10.1378/chest.11-2305 · Cited by 625
A Prospective Study of Body Mass Index, Weight Change, and Risk of Stroke in Women
Rexrode, K. M. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540430051032 · Cited by 617
Passive smoking and the risk of coronary heart disease—a meta-analysis of epidemiologic studies
He, J., Vupputuri, S., Allen, K., Prerost, M. R., Hughes, J., & Whelton, P. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903253401204 · Cited by 616
Patent Foramen Ovale and Cryptogenic Stroke in Older Patients
Handke, M., Harloff, A., Olschewski, M., Hetzel, A., & Geibel, A. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa071422 · Cited by 613
Miller, M., Cannon, C. P., Murphy, S. A., Qin, J., Ray, K. K., & Braunwald, E. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.038 · Cited by 610
The SSYLVIA Study Investigators (2004) · Stroke · doi:10.1161/01.str.0000128708.86762.d6 · Cited by 604
Cardiogenic brain embolism. The second report of the Cerebral Embolism Task Force.
ASINGER, R. W., Dyken, M. L., Fisher, M., Hart, R., & Sherman, D. G. (1989) · PubMed · Cited by 600
Self-citationFox, K. (2002) · European Heart Journal · doi:10.1053/euhj.2001.3081 · Cited by 599
Time Course of Sleep-related Breathing Disorders in First-Ever Stroke or Transient Ischemic Attack
PARRA, O., ARBOIX, A., BECHICH, S., GARCÍA-EROLES, L., MONTSERRAT, J. M., LÓPEZ, J. A., BALLESTER, E., GUERRA, J. M., & SOPEÑA, J. J. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.2.9903139 · Cited by 598
Echocardiographically Documented Mitral-Valve Prolapse: Long-Term Follow-up of 237 Patients
Nishimura, R. A., McGoon, M. D., Shub, C., Miller, F. A., Ilstrup, D. M., & Tajik, A. J. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511213132101 · Cited by 589
Efficacy of folic acid supplementation in stroke prevention: a meta-analysis
Wang, X., Qin, X., Demirtas, H., Li, J., Mao, G., Huo, Y., Sun, N., Liu, L., & Xu, X. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60854-x · Cited by 589
Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm
Homma, S., Thompson, J. L. P., Pullicino, P. M., Levin, B., Freudenberger, R. S., Teerlink, J. R., Ammon, S. E., Graham, S., Sacco, R. L., Mann, D. L., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1202299 · Cited by 584
Asinger, R. W., Mikell, F. L., Elsperger, J., & Hodges, M. (1981) · New England Journal of Medicine · doi:10.1056/nejm198108063050601 · Cited by 580
Shiroma, E. J., & Lee, I.-M. (2010) · Circulation · doi:10.1161/circulationaha.109.914721 · Cited by 578
Investigating the Relationship Between Stroke and Obstructive Sleep Apnea
Dyken, M. E., Somers, V. K., Yamada, T., Ren, Z.-Y., & Zimmerman, M. B. (1996) · Stroke · doi:10.1161/01.str.27.3.401 · Cited by 578
The Prevalence of Ulcerated Plaques in the Aortic Arch in Patients with Stroke
Amarengo, P., Duyckaerts, C., Tzourio, C., Hénin, D., Bousser, M.-G., & Hauw, J.-J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260402 · Cited by 577
Randomized Clinical Trial of Therapeutic Exercise in Subacute Stroke
Duncan, P., Studenski, S., Richards, L., Gollub, S., Lai, S. M., Reker, D., Perera, S., Yates, J., Koch, V., Rigler, S., et al. (2003) · Stroke · doi:10.1161/01.str.0000083699.95351.f2 · Cited by 575
Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199605093341902 · Cited by 575
Cabanes, L., Mas, J. L., Cohen, A., Amarenco, P., Cabanes, P. A., Oubary, P., Chedru, F., Guérin, F., Bousser, M. G., & de Recondo, J. (1993) · Stroke · doi:10.1161/01.str.24.12.1865 · Cited by 572
The economic burden of physical inactivity in Canada.
Katzmarzyk, P. T., Gledhill, N., & Shephard, R. J. (2000) · Europe PMC (PubMed Central) · Cited by 570
Agalsidase-Beta Therapy for Advanced Fabry Disease: A Randomized Trial
Banikazemi, M., Bultas, J., Waldek, S., Wilcox, W. R., Whitley, C. B., McDonald, M., Finkel, R., Packman, S., Bichet, D. G., Warnock, D. G., et al. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-2-200701160-00148 · Cited by 569
Schwamm, L. H., Fonarow, G. C., Reeves, M. J., Pan, W., Frankel, M. R., Smith, E. E., Ellrodt, G., Cannon, C. P., Liang, L., Peterson, E., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.783688 · Cited by 568
Self-citationAbdominal obesity as important component of insulin-resistance syndrome.
Després, J. (1993) · PubMed · Cited by 567
Goodpaster, B. H., DeLany, J. P., Otto, A. D., Kuller, L., Vockley, J., South-Paul, J. E., Thomas, S. B., Brown, J., McTigue, K., Hames, K. C., et al. (2010) · JAMA · doi:10.1001/jama.2010.1505 · Cited by 558
(1970) · JAMA · doi:10.1001/jama.213.7.1143 · Cited by 554
The Salt Collaborative Group (1991) · The Lancet · doi:10.1016/0140-6736(91)92233-r · Cited by 553
Hemorrhagic Transformation of Ischemic Brain Tissue: Asymptomatic or Symptomatic?
Berger, C., Fiorelli, M., Steiner, T., Schäbitz, W.-R., Bozzao, L., Bluhmki, E., Hacke, W., & von Kummer, R. (2001) · Stroke · doi:10.1161/01.str.32.6.1330 · Cited by 552
Kennedy, J., Hill, M. D., Ryckborst, K. J., Eliasziw, M., Demchuk, A. M., & Buchan, A. M. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70250-8 · Cited by 551
A Comparison of Aspirin with Placebo in Patients Treated with Warfarin after Heart-Valve Replacement
Turpie, A., Gent, M., Laupacis, A., Latour, Y., Gunstensen, J., Basile, F., Klimek, M., & Hirsh, J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199308193290802 · Cited by 547
Independent predictors of stroke in patients with atrial fibrillation: A systematic review
The Stroke Risk in Atrial Fibrillation Working Group (2007) · Neurology · doi:10.1212/01.wnl.0000267275.68538.8d · Cited by 547
Change in the Quality of Care Delivered to Medicare Beneficiaries, 1998-1999 to 2000-2001
Jencks, S. F., Huff, E. D., & Cuerdon, T. (2003) · JAMA · doi:10.1001/jama.289.3.305 · Cited by 546
The Stroke Prevention in Atrial Fibrillation Investigators (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-116-1-6 · Cited by 543
Nonfasting triglycerides and risk of ischemic stroke in the general population
Freiberg, J. J. (2008) · JAMA · doi:10.1001/jama.2008.621 · Cited by 542
Weight Loss Reduces C-Reactive Protein Levels in Obese Postmenopausal Women
Tchernof, A., Nolan, A., Sites, C. K., Ades, P. A., & Poehlman, E. T. (2002) · Circulation · doi:10.1161/hc0502.103331 · Cited by 541
(1997) · ACC Current Journal Review · doi:10.1016/s1062-1458(97)83303-x · Cited by 539
The Protective Effect of Moderate Alcohol Consumption on Ischemic Stroke
Sacco, R. L. (1999) · JAMA · doi:10.1001/jama.281.1.53 · Cited by 531
Physical activity and risk of stroke in women
Hu, F. B. (2000) · JAMA · doi:10.1001/jama.283.22.2961 · Cited by 531
Rashid, P., Leonardi-Bee, J., & Bath, P. (2003) · Stroke · doi:10.1161/01.str.0000092488.40085.15 · Cited by 530
Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous Thrombosis
Ginsburg, K. S., Liang, M. H., Newcomer, L., Goldhaber, S. Z., Schur, P. H., Hennekens, C. H., & Stampfer, M. J. (1992) · Annals of Internal Medicine · doi:10.7326/0003-4819-117-12-997 · Cited by 526 · cited 1×
“A high-quality nested, case-control study from the Physicians Health Study demonstrated no association between the elevated levels of anticardiolipin antibodies and risk for ischemic stroke.(696) A limited number of studies have examined the effect of antiphospholipid antibodies specifically on the risk for recurrent…”
BackgroundBody mass index and the risk of stroke in men
Kurth, T., Gaziano, J. M., Berger, K., Kase, C. S., Rexrode, K. M., Cook, N. R., Buring, J. E., & Manson, J. E. (2002) · Archives of Internal Medicine · doi:10.1001/archinte.162.22.2557 · Cited by 524
Frequency of Sleep Apnea in Stroke and TIA Patients: A Meta-analysis
Johnson, K. G., & Johnson, D. C. (2010) · Journal of Clinical Sleep Medicine · doi:10.5664/jcsm.27760 · Cited by 523 · cited 3×
“In a meta-analysis of 29 studies that included 2343 patients, 72% of patients with stroke or TIA were found to have sleep apnea on the basis of an AHI >5 events per hour, with 63% having an AHI >10 events per hour and 38% having an AHI >20 events per hour.(268) This meta-analysis also confirmed that central sleep apne…”
BackgroundAspirin and Risk of Hemorrhagic Stroke: A Meta-analysis of Randomized Controlled Trials
He, J., Whelton, P. K., Vu, B., & Klag, M. J. (1998) · JAMA · doi:10.1001/jama.280.22.1930 · Cited by 521
Adipocytokines and Insulin Resistance
Pittas, A. G., Joseph, N. A., & Greenberg, A. S. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031005 · Cited by 515
Sleep Apnea in Acute Cerebrovascular Diseases: Final Report on 128 Patients
Bassetti, C., & Aldrich, M. S. (1999) · Sleep · doi:10.1093/sleep/22.2.217 · Cited by 509
Ruiz-Irastorza, G., Cuadrado, M., Ruiz-Arruza, I., Brey, R., Crowther, M., Derksen, R., Erkan, D., Krilis, S., Machin, S., Pengo, V, et al. (2011) · Lupus · doi:10.1177/0961203310395803 · Cited by 506
Cigarette Smoking as a Risk Factor for Stroke: The Framingham Study
Wolf, P. A. (1988) · JAMA · doi:10.1001/jama.1988.03720070025028 · Cited by 506
Gordon, N. F., Gulanick, M., Costa, F., Fletcher, G., Franklin, B. A., Roth, E. J., & Shephard, T. (2004) · Circulation · doi:10.1161/01.cir.0000126280.65777.a4 · Cited by 505
Global experience in cervical carotid artery stent placement
Wholey, M. H., Wholey, M., Mathias, K., Roubin, G. S., Diethrich, E. B., Henry, M., Bailey, S., Bergeron, P., Dorros, G., Eles, G., et al. (2000) · Catheterization and Cardiovascular Interventions · doi:10.1002/(sici)1522-726x(200006)50:2<160::aid-ccd2>3.0.co;2-e · Cited by 498
Hematology: basic principles and practice
Goldman, J. (2013) · Bone Marrow Transplantation · doi:10.1038/bmt.2013.77 · Cited by 495
Effect of Malnutrition After Acute Stroke on Clinical Outcome
Dávalos, A., Ricart, W., Gonzalez-Huix, F., Soler, S., Marrugat, J., Molins, A., Suñer, R., & Genís, D. (1996) · Stroke · doi:10.1161/01.str.27.6.1028 · Cited by 494
Sattar, N., McConnachie, A., Shaper, A. G., Blauw, G. J., Buckley, B. M., de Craen, A. J., Ford, I., Forouhi, N. G., Freeman, D. J., Jukema, J. W., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60602-9 · Cited by 493
Miller, N. H., Hill, M., Kottke, T., & Ockene, I. S. (1997) · Circulation · doi:10.1161/01.cir.95.4.1085 · Cited by 493
Shinohara, Y., Katayama, Y., Uchiyama, S., Yamaguchi, T., Handa, S., Matsuoka, K., Ohashi, Y., Tanahashi, N., Yamamoto, H., Genka, C., et al. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70198-8 · Cited by 488
Effect of Study Setting on Anticoagulation Control
van Walraven, C., Jennings, A., Oake, N., Fergusson, D., & Forster, A. J. (2006) · Chest · doi:10.1378/chest.129.5.1155 · Cited by 487
Incidence and Risk Factors for Stroke in Pregnancy and the Puerperium
James, A. H., Bushnell, C. D., Jamison, M. G., & Myers, E. R. (2006) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000193837.87337.d7 · Cited by 483
(1997) · Annals of Neurology · doi:10.1002/ana.410420606 · Cited by 480
Jneid, H., Anderson, J. L., Wright, R. S., Adams, C. D., Bridges, C. R., Casey, D. E., Ettinger, S. M., Fesmire, F. M., Ganiats, T. G., Lincoff, A. M., et al. (2012) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.06.004 · Cited by 479
Antiphospholipid Antibodies and subsequent thrombo-occlusive events in patients with ischemic stroke
(2004) · JAMA · doi:10.1001/jama.291.5.576 · Cited by 478 · cited 3×
“The findings in older patients are more mixed.689–694 In a case-control study of 255 patients with a mean age of 66 years, the presence of an anticardiolipin antibody was associated with a significantly increased risk for ischemic stroke (adjusted OR, 2.31; 95% CI, 1.09–4.90).695 These findings were not replicated in…”
ResultInfluentialIncidence and Short-Term Prognosis of Transient Ischemic Attack in a Population-Based Study
Kleindorfer, D., Panagos, P., Pancioli, A., Khoury, J., Kissela, B., Woo, D., Schneider, A., Alwell, K., Jauch, E., Miller, R., et al. (2005) · Stroke · doi:10.1161/01.str.0000158917.59233.b7 · Cited by 476
Primary and Secondary Prevention of Cardiovascular Disease
Vandvik, P. O., Lincoff, A. M., Gore, J. M., Gutterman, D. D., Sonnenberg, F. A., Alonso-Coello, P., Akl, E. A., Lansberg, M. G., Guyatt, G. H., & Spencer, F. A. (2012) · Chest · doi:10.1378/chest.11-2306 · Cited by 476
Wilcox, R., Bousser, M.-G., Betteridge, D. J., Schernthaner, G., Pirags, V., Kupfer, S., & Dormandy, J. (2007) · Stroke · doi:10.1161/01.str.0000257974.06317.49 · Cited by 475
Post-stroke antihypertensive treatment study. A preliminary result.
Pats, & Collaborating (1995) · Chinese Medical Journal · Cited by 474
Fox, C. S., Vasan, R. S., Parise, H., Levy, D., O’Donnell, C. J., D’Agostino, R. B., & Benjamin, E. J. (2003) · Circulation · doi:10.1161/01.cir.0000058168.26163.bc · Cited by 465
Prevalence of Fabry disease in patients with cryptogenic stroke: a prospective study
Rolfs, A., Böttcher, T., Zschiesche, M., Morris, P., Winchester, B., Bauer, P., Walter, U., Mix, E., Löhr, M., Harzer, K., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67635-0 · Cited by 464
Smoking Cessation and Decreased Risk of Stroke in Women
Kawachi, I. (1993) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1993.03500020066033 · Cited by 457
Antithrombotic and Thrombolytic Therapy for Ischemic Stroke
Lansberg, M. G., O'Donnell, M. J., Khatri, P., Lang, E. S., Nguyen-Huynh, M. N., Schwartz, N. E., Sonnenberg, F. A., Schulman, S., Vandvik, P. O., Spencer, F. A., et al. (2012) · Chest · doi:10.1378/chest.11-2302 · Cited by 455
Diener, H.-C., Connolly, S. J., Ezekowitz, M. D., Wallentin, L., Reilly, P. A., Yang, S., Xavier, D., Di Pasquale, G., & Yusuf, S. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70274-x · Cited by 451
Self-citationKenet, G., Lütkhoff, L. K., Albisetti, M., Bernard, T., Bonduel, M., Brandao, L., Chabrier, S., Chan, A., deVeber, G., Fiedler, B., et al. (2010) · Circulation · doi:10.1161/circulationaha.109.913673 · Cited by 449
Homocysteine and stroke: evidence on a causal link from mendelian randomisation
Casas, J. P., Bautista, L. E., Smeeth, L. L., Sharma, P. K., & Hingorani, A. D. (2005) · The Lancet · doi:10.1016/s0140-6736(05)17742-3 · Cited by 444
Dissections of Cervical and Cerebral Arteries
Hart, R. G., & Easton, J. D. (1983) · Neurologic Clinics · doi:10.1016/s0733-8619(18)31177-0 · Cited by 443
Physical activity and stroke. A meta-analysis of observational data
Wendel-Vos, G. (2004) · International Journal of Epidemiology · doi:10.1093/ije/dyh168 · Cited by 440
Bassetti, C. L., Milanova, M., & Gugger, M. (2006) · Stroke · doi:10.1161/01.str.0000208215.49243.c3 · Cited by 439
Germain, D. P., Waldek, S., Banikazemi, M., Bushinsky, D. A., Charrow, J., Desnick, R. J., Lee, P., Loew, T., Vedder, A. C., Abichandani, R., et al. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006080816 · Cited by 438
Vaitkus, P. T., & Barnathan, E. S. (1993) · Journal of the American College of Cardiology · doi:10.1016/0735-1097(93)90409-t · Cited by 431
Patent Foramen Ovale: Innocent or Guilty?
Meissner, I., Khandheria, B. K., Heit, J. A., Petty, G. W., Sheps, S. G., Schwartz, G. L., Whisnant, J. P., Wiebers, D. O., Covalt, J. L., Petterson, T. M., et al. (2006) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.10.044 · Cited by 430
Urbanus, R. T., Siegerink, B., Roest, M., Rosendaal, F. R., de Groot, P. G., & Algra, A. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70239-x · Cited by 429 · cited 1×
“A case-control study from the Netherlands examined the association between the lupus anticoagulant and risk for stroke among women <50 years of age.(688) The lupus anticoagulant was detected in 30 of 175 patients (17%) with ischemic stroke.”
BackgroundTiming of TIAs preceding stroke: Time window for prevention is very short
Rothwell, P. M., & Warlow, C. P. (2005) · Neurology · doi:10.1212/01.wnl.0000152985.32732.ee · Cited by 428
Atherosclerotic Disease of the Aortic Arch as a Risk Factor for Recurrent Ischemic Stroke
(1996) · New England Journal of Medicine · doi:10.1056/nejm199611073351913 · Cited by 427
Mitral Annular Calcification and the Risk of Stroke in an Elderly Cohort
Benjamin, E. J., Plehn, J. F., D'Agostino, R. B., Belanger, A. J., Comai, K., Fuller, D. L., Wolf, P. A., & Levy, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208063270602 · Cited by 423
Berge, E., Abdelnoor, M., Nakstad, P., & Sandset, P. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02085-7 · Cited by 421
Abdominal Obesity and Risk of Ischemic Stroke: The Northern Manhattan Stroke Study
Suk, S.-H., Sacco, R. L., Boden-Albala, B., Cheun, J. F., Pittman, J. G., Elkind, M. S., & Paik, M. C. (2003) · Stroke · doi:10.1161/01.str.0000075294.98582.2f · Cited by 420
Sakkinen, P. A., Wahl, P., Cushman, M., Lewis, M. R., & Tracy, R. P. (2000) · American Journal of Epidemiology · doi:10.1093/aje/152.10.897 · Cited by 420
Stroke in a cohort of patients with homozygous sickle cell disease
Balkaran, B., Char, G., Morris, J. S., Thomas, P. W., Serjeant, B. E., & Serjeant, G. R. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80897-2 · Cited by 419
Sleep-Disordered Breathing and Poor Functional Outcome After Stroke
Good, D. C., Henkle, J. Q., Gelber, D., Welsh, J., & Verhulst, S. (1996) · Stroke · doi:10.1161/01.str.27.2.252 · Cited by 417
Benefits of Smoking Cessation for Longevity
Taylor, D. H., Hasselblad, V., Henley, S. J., Thun, M. J., & Sloan, F. A. (2002) · American Journal of Public Health · doi:10.2105/ajph.92.6.990 · Cited by 415
Kushwaha, S. S., Fallon, J. T., & Fuster, V. (1997) · New England Journal of Medicine · doi:10.1056/nejm199701233360407 · Cited by 412
Fabry disease: Guidelines for the evaluation and management of multi-organ system involvement
Eng, C. M., Germain, D. P., Banikazemi, M., Warnock, D. G., Wanner, C., Hopkin, R. J., Bultas, J., Lee, P., Sims, K., Brodie, S. E., et al. (2006) · Genetics in Medicine · doi:10.1097/01.gim.0000237866.70357.c6 · Cited by 411
Massie, B. M., Collins, J. F., Ammon, S. E., Armstrong, P. W., Cleland, J. G. F., Ezekowitz, M., Jafri, S. M., Krol, W. F., O'Connor, C. M., Schulman, K. A., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.801753 · Cited by 408
Self-citationSchenk, S., & Horowitz, J. F. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30566 · Cited by 407
Cleland, J. G. F., Findlay, I., Jafri, S., Sutton, G., Falk, R., Bulpitt, C., Prentice, C., Ford, I., Trainer, A., & Poole-Wilson, P. A. (2004) · American Heart Journal · doi:10.1016/j.ahj.2004.03.010 · Cited by 407
FOOD Trial Collaboration (2003) · Stroke · doi:10.1161/01.str.0000074037.49197.8c · Cited by 406
Hemorrhagic stroke in the Stroke Prevention by Aggressive Reduction in Cholesterol Levels study
Goldstein, L. B., Amarenco, P., Szarek, M., Callahan, A., Hennerici, M., Sillesen, H., Zivin, J. A., & Welch, K. M. A. (2008) · Neurology · doi:10.1212/01.wnl.0000296277.63350.77 · Cited by 405
Bose, A., Hartmann, M., Henkes, H., Liu, H. M., Teng, M. M. H., Szikora, I., Berlis, A., Reul, J., Yu, S. C. H., Forsting, M., et al. (2007) · Stroke · doi:10.1161/strokeaha.106.477711 · Cited by 405
Long-Term Safety and Efficacy of Enzyme Replacement Therapyfor Fabry Disease
Wilcox, W. R., for the International Fabry Disease Study Group, Banikazemi, M., Guffon, N., Waldek, S., Lee, P., Linthorst, G. E., Desnick, R. J., & Germain, D. P. (2004) · The American Journal of Human Genetics · doi:10.1086/422366 · Cited by 404
Lal, B. K., Beach, K. W., Roubin, G. S., Lutsep, H. L., Moore, W. S., Malas, M. B., Chiu, D., Gonzales, N. R., Burke, J. L., Rinaldi, M., et al. (2012) · The Lancet Neurology · doi:10.1016/s1474-4422(12)70159-x · Cited by 401 · cited 3×
“The overall comparison showed higher restenosis rates among patients randomized to endovascular treatment than among those assigned to surgery (OR, 2.41; 95% CI, 1.28–4.53; P=0.007).363 A more current comparison of CAS and CEA is available for CREST.371 Among 2191 CREST patients with follow-up, investigators used ultr…”
BackgroundMethodInfluentialPatra, J., Taylor, B., Irving, H., Roerecke, M., Baliunas, D., Mohapatra, S., & Rehm, J. (2010) · BMC Public Health · doi:10.1186/1471-2458-10-258 · Cited by 397
Research works printed but not linked: 12
- PROGRESS Management Committee. PROGRESS: Perindopril Protection Against Recurrent Stroke Study: characteristics of the study population at baseline. J Hypertens. 1999;17:1647–1655.
- Benavente OR McClure LA Coffey CS Conwit R Pergola PE Hart RG; for the SPS3 Investigators. The Secondary Prevention of Small Subcortical Strokes (SPS3) trial: results of the blood pressure intervention. Presented at: International Stroke Conference 2013; February 8 2013; Honolulu HI. Abstract LB8.
- Centers for Disease Control and Prevention. Diabetes Report Card 2012. Atlanta, GA: Centers for Disease Control and Prevention, US Department of Health and Human Services; 2012
- 10.1001/archinte.1991.00400060077013 · DOI · Paper page
- 10.1016/S0140-6736(05)70998-3 · doi:10.1016/s0140-6736(05)70998-3 · Paper page
- 10.1016/S0140-6736(05)70999-5 · doi:10.1016/s0140-6736(05)70999-5 · Paper page
- Deleted in press.
- Balk E, Moorthy D, Obadan N, Patel K, Ip S, Chung M, Bannuru R, Kitsios G, Sen S, Iovin R, Gaylor J, D’Ambrosio C, Lau JDiagnosis and Treatment of Obstructive Sleep Apnea in Adults. Rockville, MD: Agency for Healthcare Research and Quality; 2011.
- The ESPS Group. The European Stroke Prevention Study: principal endpoints. Lancet. 1987;2:1351–1354.
- 10.1016/S0140-6736(05)70152-5 · doi:10.1016/s0140-6736(05)70152-5 · Paper page
- Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. Fed Regist. 2008;73:30831.
- National Institute of Neurological Disorders and Stroke. Proceedings of the Stroke Disparities Advisory Panel Meeting. November 7-8 2002 Bethesda MD. http://www.ninds.nih.gov/news_and_events/proceedings/stroke_report_nov_2002.htm. Accessed April 7 2014.
Cited by
Zhang, Q., Wang, C., Zheng, M., Li, Y., Li, J., Zhang, L., Shang, X., & Yan, C. (2015) · Cerebrovascular Diseases · doi:10.1159/000369778 · Cited by 11,533
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
Jauch, E. C., Saver, J. L., Adams, H. P., Bruno, A., Connors, J. J. (., Demaerschalk, B. M., Khatri, P., McMullan, P. W., Qureshi, A. I., Rosenfield, K., et al. (2013) · Stroke · doi:10.1161/str.0b013e318284056a · Cited by 7,634
Powers, W. J., Rabinstein, A. A., Ackerson, T., Adeoye, O. M., Bambakidis, N. C., Becker, K., Biller, J., Brown, M., Demaerschalk, B. M., Hoh, B., et al. (2019) · Stroke · doi:10.1161/str.0000000000000211 · Cited by 7,468
Self-citationWhelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Self-citation
Metadata
- Authors
- Kernan, W. N., Ovbiagele, B., Black, H. R., Bravata, D. M., Chimowitz, M. I., Ezekowitz, M. D., Fang, M. C., Fisher, M., Furie, K. L., Heck, D. V., Johnston, S. C. (., Kasner, S. E., Kittner, S. J., Mitchell, P. H., Rich, M. W., Richardson, D., Schwamm, L. H., & Wilson, J. A.
- Affiliations
- Neurology, Inc (US)
- ORCID
- Venue
- Stroke
- Published
- 2014-07
- Volume
- 45
- Issue
- 7
- Pages
- 2160-2236
- ISSN
- 0039-2499 (ISSN-L)
- 1524-4628
- OpenAlex
- W2124247204
- Cited by
- 5,170
- References
- 1,095
- Citations by year
- 2026: 71 · 2025: 134 · 2024: 193 · 2023: 221 · 2022: 298 · 2021: 458 · 2020: 473 · 2019: 508 · 2018: 499 · 2017: 520 · 2016: 474 · 2015: 416 · 2014: 295
- FWCI
- 429.44
- Type
- journal article
- Language
- en
- Update notices
- Open access
- closed
- Locations
- Stroke (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Acute Ischemic Stroke Management
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cerebrovascular and Carotid Artery Diseases
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Cardiovascular and Diving-Related Complications
- Keywords
- secondary stroke prevention, ischemic stroke, transient ischemic attack, cardioembolic stroke, non-cardioembolic stroke, antithrombotic therapy, antiplatelet therapy, risk factor control, vascular obstruction, aortic arch atherosclerosis, arterial dissection, patent foramen ovale, hyperhomocysteinemia, hypercoagulability, antiphospholipid syndrome, sickle cell disease, cerebral venous thrombosis, pregnancy, intracranial hemorrhage, anticoagulation
- MeSH terms
- American Heart Association, Ischemic Attack, Transient, Humans, Societies, Medical, United States, Practice Guidelines as Topic, Stroke
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.